Literature DB >> 15114438

Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation.

Jan P Lerut1, Giuseppe Orlando, Christine Sempoux, Olga Ciccarelli, Bernard E Van Beers, Etienne Danse, Yves Horsmans, Jacques Rahier, Francine Roggen.   

Abstract

Hepatic epithelioid haemangioendotheliomas (HEHEs) are rare, low-grade vascular tumours. Five adults with HEHEs and one adult with a vascular tumour showing combined features of haemangioma and haemangioendothelioma underwent liver transplantation. Two HEHE patients had extrahepatic metastases at the time of transplantation. Median survival time following diagnosis was 10.7 years (range 40 months to 195 months). One patient needed resection of a HEHE in the breast 13 years post-transplantation. All six patients are surviving free from disease 22 to 166 months after transplantation (median 77 months). One HEHE-patient who had been treated for 8 years for vertebral and cerebral localisations is free of disease without immunosuppression 56 months after transplantation. We can conclude that liver transplantation is a valuable treatment for hepatic haemangioendothelioma, even in cases of extrahepatic localisation of the disease.

Entities:  

Mesh:

Year:  2004        PMID: 15114438     DOI: 10.1007/s00147-004-0697-4

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  14 in total

1.  [Malignant epithelioid hemangioendothelioma of the liver. Results of surgical treatment strategies].

Authors:  J M Langrehr; I Petersen; R Pfitzmann; E Lopez-Hänninen
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

Review 2.  Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma.

Authors:  Akshitkumar M Mistry; D Lee Gorden; Jacob F Busler; Alice C Coogan; Beau S Kelly
Journal:  J Gastrointest Cancer       Date:  2012-12

3.  Hepatic epithelioid hemangioendothelioma after thirteen years' follow-up: A case report and review of literature.

Authors:  Wei-Fang Mo; Yu-Ling Tong
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

4.  Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005.

Authors:  Joel A Rodriguez; Natasha S Becker; Christine A O'Mahony; John A Goss; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2007-08-21       Impact factor: 3.452

5.  Living donor liver transplantation for epithelioid hemangioendothelioma: Report of a case.

Authors:  Kiyoshi Hasegawa; Yasuhiko Sugawara; Mami Ikeda; Takeaki Ishizawa; Kenichi Ohashi; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

6.  Primary sarcoma of the liver and transplantation: a case study and literature review.

Authors:  Benjamin Bismuth; Hélène Castel; Emmanuel Boleslawski; David Buob; Marc Lambert; Nicole Declerck; Valérie Canva; Eli-Serge Zafrani; Philippe Mathurin; François-René Pruvot; Sébastien Dharancy
Journal:  Rare Tumors       Date:  2009-12-28

7.  Surgical Therapy for a Solitary Form of Hepatic Epithelioid Hemangioendothelioma: A Long-Term Survival Case.

Authors:  Nobu Oshima; Hiroaki Terajima; Ryo Hosotani
Journal:  Case Rep Gastroenterol       Date:  2009-08-28

8.  Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience.

Authors:  Carmine G Nudo; Eric M Yoshida; Vincent G Bain; Denis Marleau; Phil Wong; Paul J Marotta; Eberhard Renner; Kymberly D Watt; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

9.  Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma.

Authors:  Maria Caterina Pallotti; Margherita Nannini; Claudio Agostinelli; Simona Leoni; Valerio Di Scioscio; Anna Mandrioli; Cristian Lolli; Maristella Saponara; Stefano Pileri; Luigi Bolondi; Guido Biasco; Maria Abbondanza Pantaleo
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

10.  Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma.

Authors:  Ryan M Thomas; Thomas A Aloia; Mark J Truty; Warren H Tseng; Eugene A Choi; Steven A Curley; Jean N Vauthey; Eddie K Abdalla
Journal:  HPB (Oxford)       Date:  2013-12-06       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.